Key result
Female sex was associated with more frequent use of beta blockers (OR 1.53; 95% CI 1.41-1.66) and diuretics, but less frequent use of ACE inhibitors and calcium channel blockers compared to men.
Why the study?
Do antihypertensive treatment choices differ between men and women after adjusting for confounding factors?
Population
17,856 patients attending their first consultation at a tertiary hypertension unit between July 2000 and…
Comparison
Female sex vs Male sex
Design
Cross-sectional
Authors
Loading...
Sex differences in antihypertensive class use should not yet change practice; leaves open need for sex-stratified outcome trials.
Cross-Sectional (n=17,856)
No
Do antihypertensive treatment choices differ between men and women after adjusting for confounding factors?
Effect estimate: OR 1.53 (95% CI 1.41-1.66)
Antihypertensive treatment choices differ significantly by sex, with women receiving more diuretics and beta-blockers and fewer RAS inhibitors and CCBs than men, independent of confounding factors.
Deborde et al. (2018) conducted a cross-sectional in Hypertension (n=17,856). Female sex vs. Male sex was evaluated on Prescription of beta blockers (OR 1.53, 95% CI 1.41-1.66). Female sex was associated with more frequent use of beta blockers (OR 1.53; 95% CI 1.41-1.66) and diuretics, but less frequent use of ACE inhibitors and calcium channel blockers compared to men.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: